Clinical Trials Logo

Ischemic Heart Disease clinical trials

View clinical trials related to Ischemic Heart Disease.

Filter by:

NCT ID: NCT05369182 Not yet recruiting - Clinical trials for Coronary Artery Disease

Multicenter Registry of Coronary Flow-Derived Indexes (MulticenterFLOW)

Start date: May 1, 2022
Phase:
Study type: Observational

MulticenterFlow is a prospective, multi-center, registry study. The aim of the study is twofold: 1. To evaluate prognostic implications of coronary microvascular disease (CMD) in patients with ischemic heart disease (IHD) undergoing revascularization decision using fractional flow reserve (FFR) or other non-hyperemic pressure ratios in deferred population 2. To evaluate the efficacy of intravascular imaging-guided optimization to enhance post-revascularization coronary circulatory function, compared with angiography-only guided revascularization in revascularized population.

NCT ID: NCT05365282 Not yet recruiting - Clinical trials for Ischemic Heart Disease

Association Between Radial Artery Intervention and Development of Neuropathy in the Hand - A Prospective Study

ACCESS-IV
Start date: August 1, 2022
Phase:
Study type: Observational

Evaluation of potential nerve damage after radial CAG/PCI.

NCT ID: NCT05353348 Not yet recruiting - Clinical trials for Ischemic Heart Disease

Effect of Perioperative Short-term Iron Treatment on Allogenic Blood Transfusion

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study was to evaluate the effect of intravenous iron on perioperative anemia in elective non-cardiac major surgery patients with a history of ischemic heart disease by evaluating perioperative allogeneic red blood cell infusion. This study hypothesized that intravenous iron supplementation can reduce perioperative allogeneic red blood cell infusion and optimize perioperative anemia management.

NCT ID: NCT05349773 Enrolling by invitation - Clinical trials for Ischemic Heart Disease

The Pneumatic Tourniquet Technique for Endoscopic Radial Artery Harvest; Does it Affect Patient Hemodynamics?

Start date: May 19, 2022
Phase:
Study type: Observational

This study aims to investigate the effect of the pneumatic tourniquet technique on the patients' hemodynamics; heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP).

NCT ID: NCT05347069 Not yet recruiting - Clinical trials for Coronary Artery Disease

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

ASA-IN
Start date: May 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.

NCT ID: NCT05320926 Not yet recruiting - Clinical trials for Ischemic Heart Disease

Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Resolute Stents Implantation; C-MODE Trial

Start date: April 2022
Phase: N/A
Study type: Interventional

Previous randomized clinical trials have deomonstrated the efficacy and safety of short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), however, the single antiplatelet agent to be maintained after short-term DAPT was different. Therefore, which antiplatelet agent to be maintained after short-term DAPT needs further invstigations.

NCT ID: NCT05313919 Recruiting - Clinical trials for Coronary Artery Disease

Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Coronary Syndrome and no Significant Coronary Artery Stenosis

MOSAIC-COR
Start date: July 24, 2020
Phase:
Study type: Observational

Patients with chronic coronary syndromes (CCS) diagnosed without significant lesions in invasive coronary angiography (ischemia non-obstructive coronary artery disease - INOCA) represent approximately 50% of all patients with CCS. Results of FAME study clearly showed that evaluation of coronary circulation should not be accomplished only with visual assessment in resting conditions. Current European Society of Cardiology Guidelines of diagnosis and treatment of CCS published in 2019 emphasize the necessity of performing complex coronary physiology assessment. Invasive physiological measurements and vasoreactivity provocative tests emerged as key tools to differentiate between vasospastic angina, microcirculatory angina, overlap of both conditions or non-cardiac disease. According to contemporary literature, identification of heterogeneity of patients with INOCA is crucial for determination of adequate treatment. An appropriate pharmacotherapy has a potential to improve outcomes including grade of angina, quality of life, exertional tolerance and most important - MACCE (major adverse cardiac and cardiovascular events) free survival. However, there is a lack of evidence on each of the subtypes of INOCA especially in those with signs and symptoms of vasospasm in provocative test but without visual spasm in epicardial vessels.

NCT ID: NCT05292144 Not yet recruiting - Clinical trials for Ischemic Heart Disease

Xperience Pro PMCF Study

rEPIC04A
Start date: April 30, 2022
Phase:
Study type: Observational

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Xperience Pro to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Xperience Pro .

NCT ID: NCT05292118 Not yet recruiting - Clinical trials for Ischemic Heart Disease

Navitian PMCF Study ( rEPIC04C )

rEPIC04C
Start date: April 1, 2022
Phase:
Study type: Observational

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Navitian to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Navitian.

NCT ID: NCT05292105 Not yet recruiting - Clinical trials for Ischemic Heart Disease

NC Xperience PMCF Study( rEPIC04B)

rEPIC04B
Start date: April 30, 2022
Phase:
Study type: Observational

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of NC Xperience to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with NC Xperience .